These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 3469023

  • 1. Development and characterization of a human myelogenous leukemia cell line resistant to 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide.
    Beran M, Andersson BS.
    Cancer Res; 1987 Apr 01; 47(7):1897-904. PubMed ID: 3469023
    [Abstract] [Full Text] [Related]

  • 2. Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.
    Odaimi M, Andersson BS, McCredie KB, Beran M.
    Cancer Res; 1986 Jul 01; 46(7):3330-3. PubMed ID: 3754787
    [Abstract] [Full Text] [Related]

  • 3. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S, Kooistra AJ, de Vries EG, Mulder NH, Zijlstra JG.
    Cancer Res; 1993 Mar 01; 53(5):1064-71. PubMed ID: 8382551
    [Abstract] [Full Text] [Related]

  • 4. Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression.
    Harker WG, Slade DL, Dalton WS, Meltzer PS, Trent JM.
    Cancer Res; 1989 Aug 15; 49(16):4542-9. PubMed ID: 2568172
    [Abstract] [Full Text] [Related]

  • 5. In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia.
    Andersson BS, Beran M, Bakic M, Silberman LE, Newman RA, Zwelling LA.
    Cancer Res; 1987 Feb 15; 47(4):1040-4. PubMed ID: 3026621
    [Abstract] [Full Text] [Related]

  • 6. Toxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide in exponential- and plateau-phase Chinese hamster cell cultures.
    Wilson WR, Giesbrecht JL, Hill RP, Whitmore GF.
    Cancer Res; 1981 Jul 15; 41(7):2809-16. PubMed ID: 6894713
    [Abstract] [Full Text] [Related]

  • 7. Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II.
    Hinds M, Deisseroth K, Mayes J, Altschuler E, Jansen R, Ledley FD, Zwelling LA.
    Cancer Res; 1991 Sep 01; 51(17):4729-31. PubMed ID: 1651812
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of resistance of noncycling mammalian cells to 4'-(9-acridinylamino)methanesulfon-m-anisidide: comparison of uptake, metabolism, and DNA breakage in log- and plateau-phase Chinese hamster fibroblast cell cultures.
    Robbie MA, Baguley BC, Denny WA, Gavin JB, Wilson WR.
    Cancer Res; 1988 Jan 15; 48(2):310-9. PubMed ID: 2825971
    [Abstract] [Full Text] [Related]

  • 9. Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts.
    Zwelling LA, Estey E, Silberman L, Doyle S, Hittelman W.
    Cancer Res; 1987 Jan 01; 47(1):251-7. PubMed ID: 3024817
    [Abstract] [Full Text] [Related]

  • 10. Activity of 4'-(9-acridinylamino)methanesulfon-m-anisidide against Chinese hamster cells in multicellular spheroids.
    Wilson WR, Whitmore GF, Hill RP.
    Cancer Res; 1981 Jul 01; 41(7):2817-22. PubMed ID: 7018670
    [Abstract] [Full Text] [Related]

  • 11. In vitro chemosensitivities of human tumor stem cells to the Phase II drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and prospective in vivo correlations.
    Ahmann FR, Meyskens FL, Moon TE, Durie BG, Salmon SE.
    Cancer Res; 1982 Nov 01; 42(11):4495-8. PubMed ID: 6897012
    [Abstract] [Full Text] [Related]

  • 12. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
    Ho SB, Yan PS, Dahiya R, Neuschwander-Tetri BA, Basbaum C, Kim YS.
    J Cell Physiol; 1994 Aug 01; 160(2):213-26. PubMed ID: 7913708
    [Abstract] [Full Text] [Related]

  • 13. Isolation and characterization of an anthracycline-resistant human leukemic cell line.
    Bhalla K, Hindenburg A, Taub RN, Grant S.
    Cancer Res; 1985 Aug 01; 45(8):3657-62. PubMed ID: 3860286
    [Abstract] [Full Text] [Related]

  • 14. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA.
    Harker WG, Sikic BI.
    Cancer Res; 1985 Sep 01; 45(9):4091-6. PubMed ID: 4028002
    [Abstract] [Full Text] [Related]

  • 15. Lethal activity and kinetic response of cultured human cells to 4'-(9-acridinylamino)methanesulfon-m-anisidine.
    Drewinko B, Yang LY, Barlogie B.
    Cancer Res; 1982 Jan 01; 42(1):107-11. PubMed ID: 6895609
    [Abstract] [Full Text] [Related]

  • 16. The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs.
    Estey EH, Silberman L, Beran M, Andersson BS, Zwelling LA.
    Biochem Biophys Res Commun; 1987 Apr 29; 144(2):787-93. PubMed ID: 3034264
    [Abstract] [Full Text] [Related]

  • 17. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR, Chen SF, Behrens CH, Papp LM, Stafford MM, Sun JH, Behrens DL, Fredericks JR, Polkus ST, Sipple P.
    Cancer Res; 1994 Apr 15; 54(8):2199-206. PubMed ID: 8174127
    [Abstract] [Full Text] [Related]

  • 18. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
    Sullivan DM, Eskildsen LA, Groom KR, Webb CD, Latham MD, Martin AW, Wellhausen SR, Kroeger PE, Rowe TC.
    Mol Pharmacol; 1993 Feb 15; 43(2):207-16. PubMed ID: 8094226
    [Abstract] [Full Text] [Related]

  • 19. Scanning electron microscopy of multidrug resistant cells in haematological and mammary malignancies.
    Galimberti S, Bianchi F, Bernardini N, Mattii L, Dolfi A, Lupetti M, Petrini M.
    Cell Mol Biol (Noisy-le-grand); 1993 Jul 15; 39(5):543-51. PubMed ID: 8104068
    [Abstract] [Full Text] [Related]

  • 20. [Differential cell growth inhibition and terminal differentiation induction by chemotherapeutic agents of a human acute myelogenous leukemia cell line (HL-60) in vitro].
    Himori T, Ohnuma T, Wakui A.
    Gan To Kagaku Ryoho; 1984 Aug 15; 11(8):1605-11. PubMed ID: 6591856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.